首页|补肾活血汤辅助VAD治疗多发性骨髓瘤肾损害临床疗效及对骨代谢、肾功能的影响

补肾活血汤辅助VAD治疗多发性骨髓瘤肾损害临床疗效及对骨代谢、肾功能的影响

扫码查看
目的 探讨补肾活血汤辅助VAD治疗(长春新碱+阿霉素+地塞米松)多发性骨髓瘤肾损害的临床疗效,同时动态观察该治疗方案对骨代谢、肾功能的影响。方法 选择2019年1月—2021年1月88例确诊为多发性骨髓瘤且伴有肾损害的患者作为研究对象,采用随机数字法平均分为观察组与对照组两组:对照组给予VAD治疗方案,观察组在对照组基础上辅以补肾活血汤治疗。比较两组治疗4个疗程后临床疗效差异,与治疗前、治疗2个疗程、4个疗程后比较骨代谢指标、肾功能指标等差异。结果 观察组总有效率90。9%明显高于对照组75。0%,差异比较有统计学意义(P<0。05)。随着治疗时间延长,两组患者主症、次症及总积分均逐渐降低(P<0。05);治疗2疗程及4疗程后观察组主症、次症及总积分均低于对照组(P<0。05)。随着治疗时间延长,两组患者RANKL逐渐降低(P<0。05),ALP、OCN逐渐升高(P<0。05);治疗2疗程及4疗程后观察组RANKL均低于对照组(P<0。05),而ALP、OCN均高于对照组(P<0。05)。随着治疗时间延长,两组患者Scr、β2-MG、NGAL、KIM-1、Cys-C、尿mAlb逐渐降低(P<0。05);治疗2疗程及4疗程后观察组Scr、β2-MG、NGAL、KIM-1、Cys-C、尿mAlb均低于对照组(P<0。05)。结论 补肾活血汤辅助VAD治疗多发性骨髓瘤肾损害的临床疗效更显著,可以更好地改善症状,更好调节骨代谢,更有效地逆转肾功能损害。
Clinical Efficacy of Bushen Huoxue Decoction(补肾活血汤)Assisted with VAD in Treatment of Renal Impairment of Multiple Myeloma and Its Effects on Bone Metabolism and Renal Function
Objective To investigate the clinical efficacy of Bushen Huoxue Decoction(补肾活血汤)in assisting vincristine+doxorubicin+dexamethasone(VAD)in the treatment of renal damage caused by multiple myeloma and dynamically observe the effects of this treatment on bone metabolism and renal function.Methods A total of 88 patients diagnosed with multiple myeloma and accompanied by renal damage from January 2019 to January 2021 were selected as the research subjects,and they were e-qually divided into the observation group and the control group by the random number method.The control group was given VAD treatment,and the observation group was additionally given Bushen Huoxue Decoction on the basis of the control group.The differences of clinical effects after four courses of treatment were compared between the two groups.The differences of bone me-tabolism indexes and renal function indexes were compared before treatment and after two and four courses of treatment.Results The total effective rate(90.9%)in the observation group was significantly higher than that(75.0%)in the control group,and the difference was statistically significant(P<0.05).With the prolongation of treatment time,the main symptoms,secondary symptoms and the total score in the two groups were gradually decreased(P<0.05).After two and four courses of treatment,the main symptoms,secondary symptoms and total scores of the observation group were lower than those of the control group(P<0.05).With the prolongation of treatment,the levels of the receptor activator of nuclear factor-κB ligand(RANKL)of patients in the two groups gradually were decreased(P<0.05),while the levels of alkaline phosphatase(ALP)and osteocalcin(OCN)were gradually increased(P<0.05).After two and four courses of treatment,the level of RANKL of the observation group was lower than that of the control group(P<0.05),while the levels of ALP and OCN of the observation group were higher than those of the control group(P<0.05).With the prolongation of treatment time,the levels of serum creatinine(Scr),β2 mi-croglobulin(β2-MG),neutrophil gelatinase-associated lipocalin(NGAL),kidney injury molecule-1(KIM-1),Cystatin C(Cys-C)and urinary micro-albumin(mAlb)in patients of the two groups were gradually decreased(P<0.05).After two and four courses of treatment,the levels of Scr,β2-MG,NGAL,KIM-1,Cys-C and urinary mAlb in the observation group were lower than those in the control group(P<0.05).Conclusion Bushen Huoxue Decoction assisted VAD in the treatment of multi-ple myeloma renal impairment has a more significant clinical effect,which can better improve the symptoms and regulate the bone metabolism and more effectively reverse the renal impairment.

Bushen Huoxue Decoction(补肾活血汤)dexamethasonemultiple myelomarenal impairmentbone metabo-lismtherapeutic effect

田乐、李慧娉

展开 >

内蒙古医科大学附属医院,内蒙古呼和浩特 010050

补肾活血汤 地塞米松 多发性骨髓瘤 肾损害 骨代谢 疗效

国家中医药局科研项目内蒙古自治区自然科学基金

2019ZX0582562016MS08146

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(3)
  • 28